Anmarks Pharmaceuticals Private Limited
About Anmarks Pharmaceuticals Private Limited
Data last updated:
Anmarks Pharmaceuticals Private Limited is a private limited company based in Ajmer, Rajasthan, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 16 March 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24231RJ1995PTC009699. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Ashok Kumar Agarwal and Rajesh Kumar Jain.
Its last annual general meeting (AGM) was held on 31 May 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Post Box No. 196 Madar Gate, Ajmer, Rajasthan, India – 305001.
As per MCA filings, the company has open charges of ₹1.49 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPost Box No. 196 Madar Gate, Ajmer, Rajasthan, India – 305001
- IndustryChemicals and Materials, Industrial Chemicals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Anmarks Pharmaceuticals Private Limited
The main business activity of Anmarks Pharmaceuticals is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Anmarks Pharmaceuticals Private Limited FY 2025 filings available
Anmarks Pharmaceuticals Private Limited reported revenue of ₹14 for FY 2025.
Compounded Annual Growth Rate (CAGR) of Anmarks Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 97% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Anmarks Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Anmarks Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Anmarks Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Anmarks Pharmaceuticals Private Limited
Anmarks Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (Industrial Chemicals, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pragna Fine Chem Private Limited | ₹32 (FY 2025) | •••• | •••• | -100.0% | •••• | Ankleshwar, Gujarat, India |
| Laila Regain Bio Technologies Private Limited | ₹30 (FY 2020) | •••• | •••• | •••• | Vijayawada, Andhra Pradesh, India | |
| Rajasthan Drugs and Pharmaceuticals Limited | ₹26 (FY 2022) | •••• | •••• | -100.0% | •••• | Jaipur, Rajasthan, India |
| Chelvam Explosive Private Limited | ₹20 (FY 2024) | •••• | •••• | -100.0% | •••• | Tirunelveli, Tamil Nadu, India |
| Angoor Pharmaceuticals Private Limited | ₹16 (FY 2025) | •••• | •••• | -100.0% | •••• | Bangalore, Karnataka, India |
| Anmarks Pharmaceuticals Private Limited this company | ₹14 (FY 2025) | •••• | •••• | •••• | Ajmer, Rajasthan, India | |
| Avacus Pharmaceuticals Private Limited | ₹12 (FY 2023) | •••• | •••• | •••• | Alappuzha, Kerala, India | |
| Veseliba Pharmaceuticals Private Limited | ₹11 (FY 2024) | •••• | •••• | •••• | Kaloor, Kerala, India | |
| Akshar Noble Private Limited | ₹11 (FY 2017) | •••• | •••• | •••• | Jamnagar, Gujarat, India | |
| Winhale Pharmaceuticals Private Limited | ₹11 (FY 2025) | •••• | •••• | •••• | Tirunelveli, Tamil Nadu, India | |
| Lloyd Tar Products Private Limited | ₹10 (FY 2019) | •••• | •••• | -100.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Anmarks Pharmaceuticals by revenue in the Chemicals industry (Industrial Chemicals, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Anmarks Pharmaceuticals Private Limited
Anmarks Pharmaceuticals Private Limited is audited by SANJEEV SHRAWAN GUPTA & COMPANY for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SANJEEV SHRAWAN GUPTA & COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Anmarks Pharmaceuticals Private Limited
Anmarks Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashok Kumar Agarwal | Director | 16 Mar 1995 | 31 Years 6 Months | Current |
| Rajesh Kumar Jain | Director | 16 Mar 1995 | 31 Years 6 Months | Current |
| Rajesh Gaba | Director | 16 Mar 1995 | 31 Years 6 Months | Current |
| Madhu Narang | Director | 16 Mar 1995 | 31 Years 6 Months | Current |
Ownership and Shareholding of Anmarks Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Anmarks Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jan 2012 | Bank of Baroda | ₹10 Lakh | Open |
| 20 Jan 2012 | Bank of Baroda | ₹10 Lakh | Open |
| 05 Feb 2007 | Bank of Baroda | ₹1.29 Cr | Open |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Anmarks Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Anmarks Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Anmarks Pharmaceuticals Private Limited
Anmarks Pharmaceuticals Private Limited has 4 board changes on record since 1995: 4 appointments. The latest: Ashok Kumar Agarwal was appointed as Director on 16 Mar 1995.
Credit Ratings, Litigation & Regulatory Alerts for Anmarks Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Anmarks Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Anmarks Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Anmarks Pharmaceuticals Private Limited
Anmarks Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Anmarks Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anmarks Pharmaceuticals Private Limited
Anmarks Pharmaceuticals is an active private limited company based in Ajmer, Rajasthan, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 16 March 1995 (31+ years old) and is registered under CIN U24231RJ1995PTC009699.
Anmarks Pharmaceuticals has 4 current directors:
- Ashok Kumar Agarwal - Director
- Rajesh Kumar Jain - Director
- Rajesh Gaba - Director
- Madhu Narang - Director
No. Anmarks Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Anmarks Pharmaceuticals is U24231RJ1995PTC009699. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anmarks Pharmaceuticals was incorporated on 16 March 1995, making it 31+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Anmarks Pharmaceuticals by revenue are Pragna Fine Chem Private Limited, Laila Regain Bio Technologies Private Limited, Rajasthan Drugs and Pharmaceuticals Limited, Chelvam Explosive Private Limited, Angoor Pharmaceuticals Private Limited and 5 more, all in the Chemicals industry (Industrial Chemicals, Pharmaceuticals).
Ashok Kumar Agarwal was appointed as Director on 16 Mar 1995. Madhu Narang was appointed as Director on 16 Mar 1995. Rajesh Gaba was appointed as Director on 16 Mar 1995. Anmarks Pharmaceuticals has 4 board changes on record in total.
The registered office of Anmarks Pharmaceuticals is at Post Box No. 196 Madar Gate, Ajmer, Rajasthan, India – 305001.
Anmarks Pharmaceuticals has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh.
Anmarks Pharmaceuticals operates in the chemicals and materials industry, in the industrial chemicals segment.
No. Anmarks Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.